AstraZeneca PLC (AZN) |
|
41.58 0.63 (1.54%)
|
06-19 14:20 |
|
Open: |
41.18 |
Pre. Close: |
40.95 |
|
High:
|
41.59 |
Low:
|
41.15 |
|
Volume:
|
1,913,661 |
Market Cap:
|
111359M |
|
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
41.068 - 41.226 |
41.226 - 41.407 |
|
Low:
|
40.075 - 40.247 |
40.247 - 40.444 |
|
Close:
|
40.631 - 40.906 |
40.906 - 41.223 |
|
Technical analysis |
as of: 2019-06-19 1:55:11 PM |
|
Overall:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
| Target: |
Six months: 48.41  One year: 56.55 |
| Support: |
Support1: 38.77 Support2: 37.12 |
| Resistance: |
Resistance1: 41.45 Resistance2: 48.41 |
| Pivot: |
39.21 |
| Moving Average: |
MA(5): 40.34 MA(20): 39.00
MA(100): 39.54 MA(250): 38.69 |
| MACD: |
MACD(12,26): 0.58 Signal(9): 0.28 |
| Stochastic oscillator: |
%K(14,3): 95.73 %D(3): 94.24 |
| RSI: |
RSI(14): 70.56 |
| 52-week: |
High: 43.30 Low: 34.38 Change(%): 14.0 |
| Average Vol(K): |
3-Month: 482111 10-Days: 220686 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.AZN has closed below upper band by 4.9%. Bollinger Bands are 38.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Mon, 17 Jun 2019 16:35:19 Z
AstraZeneca Gives Detailed Data From Calquence Leukemia Study
Fri, 14 Jun 2019 15:18:52 Z
Pharma Stock Roundup: MRK Buys Small Cancer Biotech, RHHBY, MRK Drugs Get FDA Nod
Thu, 13 Jun 2019 16:17:40 Z
Keytruda & 4 Other Reasons to Invest in Merck's (MRK) Stock
Wed, 12 Jun 2019 12:56:54 Z
Pre-Market Most Active for Jun 12, 2019 : MFG, SMFG, AZN, GSK, AMD, MDSO, NOK, TSLA, QQQ, AAT, BYND, TVIX
Mon, 10 Jun 2019 16:14:37 Z
The Zacks Analyst Blog Highlights: Bristol Myers, Merck, Roche, Lilly and AstraZeneca
|
Financial Analysis |
| Growth |
|
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
|
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Sector: Healthcare |
| Industry: Drug Manufacturers - Major |
| Shares Out. (M) |
2623.55 |
| Shares Float (M) |
2623.55 |
|
% Held by Insiders
|
|
|
% Held by Institutions
|
24.50 |
|
Shares Short (K)
|
22276 |
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
3.460 |
|
EPS Est. Current Year
|
1.910 |
|
EPS Est. Next Year
|
1.700 |
|
EPS Est. Next Quarter
|
0.450 |
|
Forward EPS
|
1.860 |
|
Book Value (p.s.)
|
9.490 |
|
PEG Ratio
|
1.16 |
|
Profit Margin
|
10.41 |
|
Operating Margin
|
9.64 |
|
Return on Assets (ttm)
|
4.0 |
|
Return on Equity (ttm)
|
21.4 |
|
Qtrly Rev. Growth
|
6.0 |
|
Gross Profit (p.s.)
|
|
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
|
|
Qtrly Earnings Growth
|
74.40 |
|
Operating Cash Flow (M)
|
2370.00 |
|
Levered Free Cash Flow (M)
|
6290.00 |
Stock Valuations |
|
P/E
|
11.91 |
|
P/E Growth Ratio
|
0.01 |
|
P/BV
|
4.34 |
|
P/S
|
5919004672.00 |
|
P/CF
|
45.61 |
Dividends & Splits |
|
Dividend
|
4.869 |
|
Dividend Yield
|
0.12 |
|
Dividend Pay Date
|
2019-03-27 |
|
Ex-Dividend Date
|
2019-02-28 |
|
Forward Dividend
|
1.400 |
|
Last Split Date
|
2015-07-27 |
|
Last Split Ratio
|
-1e+010 |
|
7 Binary Options
|
|
Your Ad Here
|
|
